Literature DB >> 30538305

A banner year for immunotherapy and targeted therapy.

Jennifer W Carlisle1, Suresh S Ramalingam2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30538305     DOI： 10.1038/s41571-018-0138-4

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

Review 1.  Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice.

Authors:  Charu Aggarwal; Christian D Rolfo; Geoffrey R Oxnard; Jhanelle E Gray; Lynette M Sholl; David R Gandara
Journal:  Nat Rev Clin Oncol       Date:  2020-09-11       Impact factor: 66.675

2.  Combined Photothermotherapy and Chemotherapy of Oral Squamous Cell Carcinoma Guided by Multifunctional Nanomaterials Enhanced Photoacoustic Tomography.

Authors:  Sujuan Zeng; Shiqi Liu; Yintao Lan; Ting Qiu; Mengyu Zhou; Weijian Gao; Wenyan Huang; Lihong Ge; Jian Zhang
Journal:  Int J Nanomedicine       Date:  2021-11-02

3.  Raman Spectroscopy and Machine Learning Reveals Early Tumor Microenvironmental Changes Induced by Immunotherapy.

Authors:  Santosh Kumar Paidi; Joel Rodriguez Troncoso; Piyush Raj; Paola Monterroso Diaz; Jesse D Ivers; David E Lee; Nathan L Avaritt; Allen J Gies; Charles M Quick; Stephanie D Byrum; Alan J Tackett; Narasimhan Rajaram; Ishan Barman
Journal:  Cancer Res       Date:  2021-10-13       Impact factor: 12.701

Review 4.  Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care.

Authors:  Alina Basnet; Asrar Alahmadi; Ajeet Gajra
Journal:  Curr Oncol Rep       Date:  2022-07-28       Impact factor: 5.945

Review 5.  Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.

Authors:  Colin R Lindsay; Emily C Shaw; David A Moore; Doris Rassl; Mariam Jamal-Hanjani; Nicola Steele; Salma Naheed; Craig Dick; Fiona Taylor; Helen Adderley; Fiona Black; Yvonne Summers; Matt Evans; Alexandra Rice; Aurelie Fabre; William A Wallace; Siobhan Nicholson; Alex Haragan; Phillipe Taniere; Andrew G Nicholson; Gavin Laing; Judith Cave; Martin D Forster; Fiona Blackhall; John Gosney; Sanjay Popat; Keith M Kerr
Journal:  Br J Cancer       Date:  2021-09-06       Impact factor: 9.075

6.  Direct Ras G12C inhibitors: crossing the rubicon.

Authors:  Colin R Lindsay; Fiona H Blackhall
Journal:  Br J Cancer       Date:  2019-06-26       Impact factor: 7.640

7.  The landscape of immune checkpoint inhibitor plus chemotherapy versus immunotherapy for advanced non-small-cell lung cancer: A systematic review and meta-analysis.

Authors:  Chengdi Wang; Wenliang Qiao; Yuting Jiang; Min Zhu; Jun Shao; Tao Wang; Dan Liu; Weimin Li
Journal:  J Cell Physiol       Date:  2019-11-06       Impact factor: 6.384

8.  The Current Landscape of Clinical Studies Focusing on Thyroid Cancer: A Comprehensive Analysis of Study Characteristics and Their Publication Status.

Authors:  Yihao Liu; Bin Li; Qiuyi Zheng; Jia Xu; Jie Li; Fenghua Lai; Bo Lin; Sui Peng; Weiming Lv; Haipeng Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-20       Impact factor: 5.555

9.  Comparison of sampling methods for next generation sequencing for patients with lung cancer.

Authors:  Kei Kunimasa; Shingo Matsumoto; Kazumi Nishino; Keiichiro Honma; Noboru Maeda; Hanako Kuhara; Motohiro Tamiya; Takako Inoue; Takahisa Kawamura; Toru Kimura; Tomohiro Maniwa; Jiro Okami; Koichi Goto; Toru Kumagai
Journal:  Cancer Med       Date:  2022-03-10       Impact factor: 4.711
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.